Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
| Clinical Trial | Principal Investigator | Related Conditions |
|---|---|---|
| US National OCS Liver Perfusion (OLP) Registry Study Id: NCT05940857 Start Date: - End Date: |
|
|
| EVR and EPO for Liver Transplant Tolerance Study Id: NCT06832189 Start Date: - End Date: |
|
|
| Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) Study Id: NCT06263426 Start Date: - End Date: |
|
|
| Expanding Liver Transplant Immunosuppression Minimization Via Everolimus Study Id: NCT06280950 Start Date: - End Date: |
|
|
| KIDney Injury in Times of COVID-19 (KIDCOV) Study Id: NCT04705766 Start Date: - End Date: |
|
|
| Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol Study Id: NCT02402439 Start Date: - End Date: |
|
|
| Liver Transplantation With Tregs at UCSF Study Id: NCT03654040 Start Date: - End Date: |
|
|
| Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction Study Id: NCT02474199 Start Date: - End Date: |
|
|
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Study Id: NCT02188719 Start Date: - End Date: |
|
|
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Study Id: NCT02188719 Start Date: - End Date: |
|
|
| Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study ) Study Id: NCT02244801 Start Date: - End Date: |
|
|
| Extended Follow-Up After Islet Transplantation in T1D Study Id: NCT01369082 Start Date: - End Date: |
|
|
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Study Id: NCT00320606 Start Date: - End Date: |
|
|
| Pancreatic Islet Transplantation Into the Gastric Submucosa Study Id: NCT01571817 Start Date: - End Date: |
|
|
| Islet Transplantation in Type 1 Diabetes Study Id: NCT00434811 Start Date: - End Date: |
|
|
| Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes Study Id: NCT00434850 Start Date: - End Date: |
|